|
Goldman-Mazur S, Jurczyszyn A, Castillo JJ, Waszczuk-Gajda A, Grząśko N, Radocha J, Bittrich M, Kortüm KM, Gozzetti A, Usnarska-Zubkiewicz L, Davila Valls J, Jayabalan DS, Niesvizky R, Kelman J, Coriu D, Rosiñol L, Szukalski Ł, González-Calle V, Mateos MV, Jamroziak K, Hus I, Avivi I, Cohen Y, Suska A, Chappell A, Madduri D, Chhabra S, Kleman A, Hari P, Delforge M, Robak P, Gentile M, Kozłowska I, Goldberg SL, Czepiel J, Silbermann R, Olszewski AJ, Barth P, Mikala G, Chim CS, Długosz-Danecka M, Grosicki S, Vesole DH.
"A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma." American Journal of Hematology, vol. 95, no. 5, 2020, pp. 503-509.
|
|
Goldman-Mazur S, Jurczyszyn A, Castillo JJ, Waszczuk-Gajda A, Grząśko N, Radocha J, Bittrich M, Kortüm KM, Gozzetti A, Usnarska-Zubkiewicz L, Valls JD, Jayabalan DS, Niesvizky R, Kelman J, Coriu D, Rosiñol L, Szukalski Ł, González-Calle V, Mateos MV, Jamroziak K, Hus I, Avivi I, Cohen Y, Mazur P, Suska A, Chappell A, Madduri D, Chhabra S, Kleman A, Hari P, Delforge M, Robak P, Gentile M, Kozłowska I, Goldberg SL, Czepiel J, Długosz-Danecka M, Silbermann R, Olszewski AJ, Barth P, Mikala G, Chim CS, Vesole DH.
"Different MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patients." Leukemia & Lymphoma, 2020, pp. 1-9.
|
|
Chudasama R, Barth P.
"Risk Stratification of Precursors to Multiple Myeloma in 2020." Rhode Island medical journal (2013), vol. 103, no. 3, 2020, pp. 46-47.
|
|
Barth P, Castillo JJ, Olszewski AJ.
"Outcomes of secondary solid tumor malignancies among patients with myeloma: A population-based study." Cancer, vol. 125, no. 4, 2019, pp. 550-558.
|
|
Orcutt X, Barth P, Olszewski AJ.
"Prognostic significance of upfront radiation therapy in patients with multiple myeloma." American Journal of Hematology, vol. 94, no. 7, 2019, pp. E190-E194.
|
|
Olszewski AJ, Barth PM, Reagan JL.
"Use of bone-modifying agents and clinical outcomes in older adults with multiple myeloma." Cancer medicine, vol. 8, no. 16, 2019, pp. 6945-6954.
|
|
Apor E, Connell NT, Faricy-Anderson K, Barth P, Youssef R, Fenton M, Sikov WM, Thomas A, Rosati K, Schumacher A, Lombardo A, Korber S, Khurshid H, Safran H, Mega A.
"Prechemotherapy Education: Reducing Patient Anxiety Through Nurse-Led Teaching Sessions
." Clinical journal of oncology nursing, vol. 22, no. 1, 2018, pp. 76-82.
|
|
Barth P, Vale C, Chambers AB, Reagan JL.
"The next generation of therapy for multiple myeloma: a review of ongoing clinical trials utilizing ClinicalTrials.gov." Future oncology (London, England), vol. 14, no. 19, 2018, pp. 1965-1976.
|
|
Safran H, Leonard KL, Perez K, Vrees M, Klipfel A, Schechter S, Oldenburg N, Roth L, Shah N, Rosati K, Rajdev L, Mantripragada K, Sheng IY, Barth P, DiPetrillo TA.
"Tolerability of ADXS11-001 Lm-LLO Listeria-Based Immunotherapy With Mitomycin, Fluorouracil, and Radiation for Anal Cancer." International Journal of Radiation Oncology*Biology*Physics, vol. 100, no. 5, 2018, pp. 1175-1178.
|
|
Zibelman M, Barth P, Handorf E, Smaldone MC, Kutikov A, Uzzo RG, Bilusic M, Plimack ER, Wong YN, Geynisman DM.
"A review of interventional clinical trials in renal cell carcinoma: a status report from the ClinicalTrials.gov WebSite." Clinical genitourinary cancer, vol. 13, no. 2, 2015, pp. 142-9.
|
|
Barth P, Dulaimi Al-Saleem E, Edwards KW, Millis SZ, Wong YN, Geynisman DM.
"Metastatic Extramammary Paget's Disease of Scrotum Responds Completely to Single Agent Trastuzumab in a Hemodialysis Patient: Case Report, Molecular Profiling and Brief Review of the Literature." Case reports in oncological medicine, vol. 2015, 2015, pp. 895151.
|
